Literature DB >> 23656581

The novel human polyomaviruses HPyV6, 7, 9 and beyond.

Bernhard Ehlers1, Ulrike Wieland.   

Abstract

Since the discovery of Merkel cell polyomavirus and its causative association with Merkel cell carcinoma (MCC), six human polyomaviruses (HPyVs) have been identified that, so far, lack any disease association, which include the human polyomaviruses (HPyV) 6, 7, 9, 10 and 12 as well as the Saint Louis polyomavirus (STLPyV). PCR studies revealed that HPyV6 and HPyV7 are shed from the skin of healthy subjects and of patients suffering from various skin tumours. HPyV6, 7 and 9 were sporadically detected in body fluids and excretions of immunocompromised patients and healthy subjects. HPyV10 was identified in papillomavirus-induced anal condylomas, and variants of HPyV10, named MWPyV and MX polyomavirus (human) (MXPyV), as well as STLPyV were detected in faeces of diarrheal and healthy children. HPyV12 was discovered in organs of the digestive tract of patients suffering from various malignant diseases. Serological studies using capsomer-based or virus-like particle (VLP)-based enzyme-linked immunosorbent assay (ELISA) revealed that HPyV6, 7, 9 and 12 are circulating in the human population. As all other HPyVs, the novel polyomaviruses encode small and large T antigens and thus are potentially oncogenic. However, several studies have revealed a lack of association of HPyV6, 7 and 9 with numerous human tumours. In the future, it will be important to unravel the cell types and body compartments of the novel HPyVs' reservoir and to search for possible associations with cancer and non-malignant diseases.
© 2013 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  ELISA; Human polyomavirus; PCR; polyomaviridae; seroprevalence

Mesh:

Substances:

Year:  2013        PMID: 23656581     DOI: 10.1111/apm.12104

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  13 in total

1.  Analysis of JC virus DNA replication using a quantitative and high-throughput assay.

Authors:  Jong Shin; Paul J Phelan; Panharith Chhum; Nazym Bashkenova; Sung Yim; Robert Parker; David Gagnon; Ole Gjoerup; Jacques Archambault; Peter A Bullock
Journal:  Virology       Date:  2014-08-24       Impact factor: 3.616

2.  Cutaneous manifestations of human immunodeficiency virus: a clinical update.

Authors:  Kirstin Altman; Erin Vanness; Ryan P Westergaard
Journal:  Curr Infect Dis Rep       Date:  2015-03       Impact factor: 3.725

3.  Exposure to raccoon polyomavirus (RacPyV) in free-ranging North American raccoons (Procyon lotor).

Authors:  M E Church; F N Dela Cruz; M Estrada; C M Leutenegger; P A Pesavento; K D Woolard
Journal:  Virology       Date:  2016-01-21       Impact factor: 3.616

4.  Seroepidemiology of Human Polyomaviruses in a US Population.

Authors:  Anala Gossai; Tim Waterboer; Heather H Nelson; Angelika Michel; Martina Willhauck-Fleckenstein; Shohreh F Farzan; Anne G Hoen; Brock C Christensen; Karl T Kelsey; Carmen J Marsit; Michael Pawlita; Margaret R Karagas
Journal:  Am J Epidemiol       Date:  2015-12-13       Impact factor: 4.897

5.  Novel Human Polyomavirus Noncoding Control Regions Differ in Bidirectional Gene Expression according to Host Cell, Large T-Antigen Expression, and Clinically Occurring Rearrangements.

Authors:  Elvis T Ajuh; Zongsong Wu; Emma Kraus; Fabian H Weissbach; Tobias Bethge; Rainer Gosert; Nicole Fischer; Hans H Hirsch
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

6.  Human polyomavirus and human papillomavirus prevalence and viral load in non-malignant tonsillar tissue and tonsillar carcinoma.

Authors:  Stephan Herberhold; Martin Hellmich; Marcus Panning; Eva Bartok; Steffi Silling; Baki Akgül; Ulrike Wieland
Journal:  Med Microbiol Immunol       Date:  2016-11-10       Impact factor: 4.148

7.  A Role of Sp1 Binding Motifs in Basal and Large T-Antigen-Induced Promoter Activities of Human Polyomavirus HPyV9 and Its Variant UF-1.

Authors:  Ugo Moens; Xiaobo Song; Marijke Van Ghelue; John A Lednicky; Bernhard Ehlers
Journal:  Int J Mol Sci       Date:  2017-11-14       Impact factor: 5.923

8.  Insights into the initiation of JC virus DNA replication derived from the crystal structure of the T-antigen origin binding domain.

Authors:  Gretchen Meinke; Paul J Phelan; Radha Kalekar; Jong Shin; Jacques Archambault; Andrew Bohm; Peter A Bullock
Journal:  PLoS Pathog       Date:  2014-02-20       Impact factor: 6.823

9.  Current views and advances on Paediatric Virology: An update for paediatric trainees.

Authors:  Ioannis N Mammas; Anne Greenough; Maria Theodoridou; Anna Kramvis; Iliana Christaki; Chryssie Koutsaftiki; Maria Koutsaki; Dimitra M Portaliou; Georgia Kostagianni; Paraskevi Panagopoulou; George Sourvinos; Demetrios A Spandidos
Journal:  Exp Ther Med       Date:  2015-11-24       Impact factor: 2.447

10.  Structural Based Analyses of the JC Virus T-Antigen F258L Mutant Provides Evidence for DNA Dependent Conformational Changes in the C-Termini of Polyomavirus Origin Binding Domains.

Authors:  Gretchen Meinke; Paul J Phelan; Jong Shin; David Gagnon; Jacques Archambault; Andrew Bohm; Peter A Bullock
Journal:  PLoS Pathog       Date:  2016-01-06       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.